The inhibitory effect of friedelan-3-one on VEGF-induced Kaposi’s sarcoma cell proliferation via apoptotic cell death induction [39] and on breast cancer MCF-7 cell growth associated with p53 and caspase activation [40] were also reported. This evidence concerns the gene TP53 and breast cancer.